SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-22-003055
Filing Date
2022-08-11
Accepted
2022-08-11 06:30:34
Documents
15
Period of Report
2022-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk2228294.htm   iXBRL 8-K 34464
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 89369
7 image0.jpg GRAPHIC 4528
  Complete submission text file 0001178913-22-003055.txt   327725

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA entx-20220811.xsd EX-101.SCH 4736
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE entx-20220811_def.xml EX-101.DEF 18408
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20220811_lab.xml EX-101.LAB 28721
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20220811_pre.xml EX-101.PRE 20644
9 EXTRACTED XBRL INSTANCE DOCUMENT zk2228294_htm.xml XML 6885
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 221153548
SIC: 2836 Biological Products, (No Diagnostic Substances)